glp-1 and prostate cancer Targeting obesity, metabolic syndrome, cancer: agonists as emerging therapeutic agents | Discover Oncology Unlocking the multifaceted roles of

Common Side Effects Nausea, vomiting, diarrhea, constipation, abdominal pain, headache, and fatigue

All in all, I didnt see a pattern of serious medical risks, but I did notice recurring communication issues that reinforced my own experience with the sudden website changes

It also slows digestion and makes you feel full

Orforglipron treatment was also associated with slower gastric emptying time and short-term weight loss, all of which are consistent with drug class effects , with up to 5.4 kg loss over 4 weeks in higher-dose cohorts

They can be: expensive insurance-dependent associated with side effects challenging to maintain indefinitely Many people regain weight after stopping GLP-1 drugs, because appetite signaling returns to baseline

This is a game-changer, says Dr